(i) To determine the relationship between primary aldosteronism (PA) prevalence and medication adherence. (ii) To build a decision analysis model to test the cost effectiveness of a CAT-guided approach for PA screening in patient swith apparent TRH, compared with a nonselective approach. Here, TRH is linked to primary aldosteronism.